Ascentage Pharma Group International (ASPHF) to Release Earnings on Wednesday

Ascentage Pharma Group International (OTCMKTS:ASPHF) will likely be releasing its results before the market opens on Wednesday, March 25th. Analysts expect Ascentage Pharma Group International to post earnings of ($0.1043) per share and revenue of $44.6340 million for the quarter.

Ascentage Pharma Group International Price Performance

ASPHF stock opened at $8.48 on Wednesday. The company’s fifty day moving average price is $8.48 and its 200-day moving average price is $8.91. Ascentage Pharma Group International has a one year low of $7.50 and a one year high of $10.65.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International (OTCMKTS:ASPHF) is a clinical-stage biopharmaceutical company headquartered in Beijing, China, with a strategic presence in the United States. The company focuses on the discovery and development of targeted small-molecule therapies that modulate programmed cell death, leveraging a deep understanding of the Bcl-2 family of proteins.

Ascentage’s core activities center on the research and development of apoptosis regulators, including both Bcl-2 selective and dual Bcl-2/Bcl-xL inhibitors.